Bios

Anna D. Barker, Ph.D.
Deputy Director, Advanced Technologies and Strategic Partnerships
National Cancer Institute

Dr. Barker serves as the Deputy Director for Advanced Technologies and Strategic Partnerships of the National Cancer Institute (NCI). In this role she plans and coordinates the implementation of integrative, multi-disciplinary, and multi-sector programs to accelerate the development and translation of new knowledge and advanced technologies into effective interventions to prevent, detect, and treat cancer. Under her leadership, the NCI has recently launched programs in bioinformatics and nanotechnology and is currently developing initiatives in proteomics and biospecimens to enable cancer research. Dr. Barker completed her Ph.D. at the Ohio State University, where she trained in immunology and microbiology. Her research interests include experimental therapeutics, tumor immunology, and free-radical biochemistry in cancer etiology, prevention, and treatment.

Dr. Barker has a long history in research and the leadership and management of research and development, technology transfer, and product commercialization in the non-profit and private sectors. Prior to entering the biotechnology sector, she was a senior executive at Battelle Memorial Institute for 18 years where she developed and led a large group of scientists and technical staff, working in areas such as drug discovery and development, pharmacology and biotechnology, including several NCI sponsored research programs. In the private sector she co-founded and served as the CEO of a public biotechnology company, focused in therapeutics discovery and development; and subsequently founded and served as the CEO of a private company dedicated to the transfer and deployment of technologies to prevent, diagnose, and treat cancer.

She is a member of the Steering Committee of C-Change and Chairperson of the C-Change Cancer Research Team. She is a member of the DOD Breast Cancer Research Program Integration Panel, and a past chairperson of the BCRP Integration Panel. Dr. Barker has served in several capacities for the American Association for Cancer Research (AACR), including the Board of Directors and chairperson of the Public Science Policy and Legislative Affairs Committee; and the NCI, including membership on the Board of Scientific Counselors for the Division of Cancer Etiology and chairperson of the Cancer Center Support Review Study Section. Dr. Barker has received a number of awards for her contributions to research, cancer patients, professional and advocacy organizations, and the ongoing national effort to prevent and cure cancer, including a named fellowship from the AACR.

Kenneth H. Buetow, Ph.D.
Associate Director for Bioinformatics and Information Technology
Director, NCI Center for Bioinformatics
National Cancer Institute

View PDF

Kenneth H. Buetow, Ph.D., is the National Cancer Institute (NCI) Associate Director for Bioinformatics and Information Technology and the Director of the NCI Center for Bioinformatics (NCICB). As Director of the NCICB, Dr. Buetow oversees coordination and deployment of informatics in support of NCI research initiatives and the Center’s participation in the evaluation and prioritization of the NCI’s biomedical informatics research portfolio. Dr. Buetow initiated the cancer Biomedical Informatics Grid^® (caBIG^®) pilot project and oversees its activities. Dr. Buetow is also the Chief of the NCI Laboratory of Population Genetics (LPG). The LPG conducts human genetic and genomics research, both at the bench and using informatics tools. He has spearheaded efforts of the Genetic Annotation Initiative (GAI), an attempt to identify variant forms of the cancer genes identified through the NCI Cancer Genome Anatomy Project (CGAP). Prior to his position at NCI, Dr. Buetow was at the Fox Chase Cancer Center in Philadelphia, PA. Dr. Buetow received his doctorate of philosophy degree in human genetics from the University of Pittsburgh in 1985.